| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/13/1999 | EP0889726A1 Novel cycloalkyl substituted imidazoles |
| 01/13/1999 | EP0847278A4 Analogs of parathyroid hormone |
| 01/13/1999 | EP0789567A4 A method for treating vascular headaches |
| 01/13/1999 | EP0757670B1 Benzamide derivatives as vasopressin antagonists |
| 01/13/1999 | EP0750664A4 Reproduction and utilization of functional human tissue |
| 01/13/1999 | EP0731787B1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
| 01/13/1999 | EP0671910A4 Glaucoma treatment. |
| 01/13/1999 | EP0555327B1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
| 01/13/1999 | CN1205010A Isoxazolidine derivatives |
| 01/13/1999 | CN1205009A Pyrazolopyrimidines type compound |
| 01/13/1999 | CN1204533A Medicine for treatment of mammary gland disease and method for producing thereof |
| 01/13/1999 | CN1041631C Novel carbocyclic nucleoside agents useful as selective inhititors of proinflammatory cell factor |
| 01/12/1999 | US5859271 Inhibitors of phospholipase that prevent phospholipase mediated injury, injury due to oxidation, and inflammation; side effect reduction |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859253 Metalloproteinase inhibitors |
| 01/12/1999 | US5859246 Treating neuropsychological disorders |
| 01/12/1999 | US5859229 For inhibition of gene expression of human cyclooxygenase 2 by binding to specific untranslated regions of messenger rna; treatment of premature labor, preeclampsia, endometriosis, rheumatoid arthritis |
| 01/12/1999 | US5859204 Non-antigenic, non-immunogenic superior coagulant human/porcine hybrid by site directed mutagenesis; hemophilia |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859191 Method for the site-specific modification of peptide alpha amines |
| 01/12/1999 | US5859067 Preparing bis(2-hydroxy-1-naphthyl)decane from the corresponding diacid; forming acid dichloride; treating with 2-naphthol; rearrangement; reduction; inhibits action of adenosine triphosphatase |
| 01/12/1999 | US5859062 Guanylhydrazones and their use to treat inflammatory conditions |
| 01/12/1999 | US5859058 Administering ng-monomethyl-l-arginine |
| 01/12/1999 | US5859054 Leukotriene B4 derivatives, process for their production and their use as pharmaceutical agents |
| 01/12/1999 | US5859047 Antiarthritic agents, nervous system disorders |
| 01/12/1999 | US5859044 Treating diabetes, hyperglycemia, obesity; increasing content of lean meat in animals |
| 01/12/1999 | US5859041 Substituted imidazoles having cytokine inhibitory activity |
| 01/12/1999 | US5859034 Tri-substituted phenyl compounds which have useful pharmaceutical activity |
| 01/12/1999 | US5859031 Small molecule inhibitors of rotamase enzyme activity |
| 01/12/1999 | US5859029 Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present |
| 01/12/1999 | US5859025 Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use |
| 01/12/1999 | US5859021 Antiviral combinations |
| 01/12/1999 | US5859015 N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859012 Inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859011 Dihydropyridine derivatives as bradykinin antagonist |
| 01/12/1999 | US5859008 Arylalkyl diazinones |
| 01/12/1999 | US5859006 Tetracyclic derivatives; process of preparation and use |
| 01/12/1999 | US5859003 Antiallergens, antiasthmatics |
| 01/12/1999 | US5859002 HIV protease inhibitors |
| 01/12/1999 | US5859000 Method for reducing mast cell mediated allergic reactions |
| 01/12/1999 | US5858995 Administering to humans and animals in the treatment of diseases caused by abnormal bone metabolism |
| 01/12/1999 | US5858994 Carbohydrate conjugates as inhibitors of cell adhesion |
| 01/12/1999 | US5858991 Administering a polysaccharide toxin to reduce scarring and to provide reduced vessel density at the site of the wound |
| 01/12/1999 | US5858983 Inhibiting binding of cell bearing selectin protein to molecule or cell bearing sialyl-lewis x determinant by contacting with antibody bearing said determinant |
| 01/12/1999 | US5858979 Anticoagulant peptides |
| 01/12/1999 | US5858964 Immunosuppressant |
| 01/12/1999 | US5858758 Human serine protease precursor |
| 01/12/1999 | US5858753 Purified, isolated polynucleotide coding catalytic subunit polypeptide similar to phosphatidylinisitol 3-kinase; anticancer agents; antiproliferative agents |
| 01/12/1999 | US5858719 Polynucleotides encoding human ATP binding-cassette transport protein and methods of use |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858701 DNA encoding an insulin receptor substrate |
| 01/12/1999 | US5858684 Contacting recombinant cell with test compound which is not verapamil or gallopamil, determining ability of compound to affect activities of inorganic ion receptor; determination of agonist and antagonist drugs |
| 01/10/1999 | CA2236493A1 Mura |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/08/1999 | CA2229464A1 Hfizg53 |
| 01/07/1999 | WO1999000500A1 Calcium-binding phosphoprotein |
| 01/07/1999 | WO1999000494A2 Cell activation process and reagents therefor |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000404A1 Secreted proteins |
| 01/07/1999 | WO1999000391A1 Tricyclic pyrazolo-pyridazinone analogues as gaba-a receptor ligands |
| 01/07/1999 | WO1999000387A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 01/07/1999 | WO1999000384A1 New quinoxaline dione derivatives, the production thereof and use of the same in medicaments |
| 01/07/1999 | WO1999000383A1 Eprosartan monohydrate |
| 01/07/1999 | WO1999000379A1 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide derivatives, their preparation and application in therapy |
| 01/07/1999 | WO1999000371A1 Phenylalkyl derivatives with thrombin-inhibiting effect |
| 01/07/1999 | WO1999000368A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 01/07/1999 | WO1999000361A1 Ace-inhibitor nitric salts |
| 01/07/1999 | WO1999000356A1 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 01/07/1999 | WO1999000141A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 01/07/1999 | WO1999000140A2 Accelerating animal hoof growth with somatotropin |
| 01/07/1999 | WO1999000137A2 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | WO1999000136A1 Control of acidic gut syndrome |
| 01/07/1999 | WO1999000132A1 Use of phospholamban inhibitors for increasing coronary flow |
| 01/07/1999 | WO1999000129A1 Calcium blockers to treat proliferative vitreoretinopathy |
| 01/07/1999 | WO1999000126A1 Antithrombotic agents |
| 01/07/1999 | WO1999000116A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | WO1999000079A1 Skin aging and wound treatment using cell migration agents |
| 01/07/1999 | WO1999000015A1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 01/07/1999 | WO1998044893A3 Method and formulation for treating vascular disease |
| 01/07/1999 | WO1998039464A3 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | WO1998032853A3 Secreted proteins and polynucleotides encoding them |
| 01/07/1999 | EP0889136A1 Exocellular polysaccharide produced by streptococcus thermophilus |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889036A1 HIV protease inhibitors |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888373A1 Smooth muscle cell lim protein |
| 01/07/1999 | EP0888358A1 Piperidine derivatives |
| 01/07/1999 | EP0888357A1 Azaspiro derivatives |
| 01/07/1999 | EP0888356A1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 01/07/1999 | EP0888353A1 Novel n-7-heterocyclyl pyrrolo 2,3-d]pyridines and their use |
| 01/07/1999 | EP0888352A1 Fused imidazole derivatives as multidrug resistance modulators |
| 01/07/1999 | EP0888351A1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
| 01/07/1999 | EP0888350A1 Azolobenzazepine derivatives as neurologically active agents |
| 01/07/1999 | EP0888349A1 Pyrrolopyrimidines and processes for their preparation |
| 01/07/1999 | EP0888344A1 Spirocycle integrin inhibitors |
| 01/07/1999 | EP0888341A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |